MICHELLE ROSEN: Open Payments
NPI 1184117376 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 21 payments from 5 companies in 2025. Trend: 2023 $196 · 2024 $1,507 · 2025 $1,207
Long term medical supply or device loan: $1,000Food & beverage: $207
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $1,068 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Incyte Corporation | 2 | $43 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $23 |
Products named: KISQALI, Enhertu, Jakafi, KEYTRUDA, Trodelvy.
Industry payments across VA — which companies pay providers there.
